Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma

被引:518
作者
Bousquet, Jean [1 ,2 ,3 ]
Mantzouranis, Eva [4 ]
Cruz, Alvaro A. [5 ]
Ait-Khaled, Nadia [6 ]
Baena-Cagnani, Carlos E. [7 ,8 ]
Bleecker, Eugene R. [9 ]
Brightling, Chris E. [10 ]
Burney, Peter [11 ]
Bush, Andrew [11 ,12 ]
Busse, William W. [15 ]
Casale, Thomas B. [16 ]
Chan-Yeung, Moira [17 ]
Chen, Rongchang [18 ]
Chowdhury, Badrul [19 ]
Chung, Kian Fan [11 ,13 ]
Dahl, Ronald [20 ]
Drazen, Jeffrey M. [21 ]
Fabbri, Leonardo M. [22 ]
Holgate, Stephen T. [23 ]
Kauffmann, Francine [2 ,3 ]
Haahtela, Tari [24 ]
Khaltaev, Nikolai [25 ]
Kiley, James P. [26 ]
Masjedi, Mohammad R. [28 ]
Mohammad, Yousser [29 ]
O'Byrne, Paul [30 ]
Partridge, Martyn R. [14 ]
Rabe, Klaus F. [31 ]
Togias, Alkis [27 ]
van Weel, Christiaan [32 ]
Wenzel, Sally [33 ]
Zhong, Nanshan [18 ]
Zuberbier, Torsten [34 ]
机构
[1] Hop Arnaud Villeneuve, Serv Malad Resp, Univ Hosp, F-34295 Montpellier 5, France
[2] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France
[3] UMRS 1018, Villejuif, France
[4] WHO, Geneva, Switzerland
[5] Univ Fed Bahia, ProAR FMB, Salvador, BA, Brazil
[6] Union, Paris, France
[7] Catholic Univ, Fac Med, Cordoba, Argentina
[8] Univ Genoa, Sch Specializat, I-16126 Genoa, Italy
[9] Wake Forest Univ Hlth Sci, Winston Salem, NC USA
[10] Inst Lung Hlth, Leicester, Leics, England
[11] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England
[12] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, London SW7 2AZ, England
[13] Royal Brompton Hosp, Biomed Res Unit, London, England
[14] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, NHLI Div, London SW7 2AZ, England
[15] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA
[16] Creighton Univ, Omaha, NE 68178 USA
[17] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[18] Guangzhou Med Univ, Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China
[19] US FDA, Silver Spring, MD USA
[20] Aarhus Univ Hosp, Aarhus, Denmark
[21] Brigham & Womens Hosp, Boston, MA 02115 USA
[22] Univ Modena & Reggio Emilia, Modena, Italy
[23] Southampton Gen Hosp, Southampton, Hants, England
[24] Helsinki Univ Hosp, Skin & Allergy Hosp, Helsinki, Finland
[25] Global Alliance Chron Resp Dis, Geneva, Switzerland
[26] NHLBI, NIH, DHHS, Bethesda, MD 20892 USA
[27] NIAID, Bethesda, MD 20892 USA
[28] NRITLD, CRDRC, Tehran, Iran
[29] Tishreen Univ, Sch Med, Latakia, Syria
[30] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada
[31] Leiden Univ, Med Ctr, NL-2300 RA Leiden, Netherlands
[32] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[33] Univ Pittsburgh, Pittsburgh, PA 15260 USA
[34] Charite Univ Med Berlin, Dept Dermatol & Allergy, Allergy Ctr Charite, Berlin, Germany
基金
英国惠康基金; 英国医学研究理事会;
关键词
Asthma; severity; control; risk; definition; GARD; LUNG-FUNCTION; INHALED CORTICOSTEROIDS; LOW-INCOME; FOLLOW-UP; PRESCHOOL-CHILDREN; CHILDHOOD ASTHMA; CLUSTER-ANALYSIS; HIGH-RISK; PHENOTYPES; RESPONSIVENESS;
D O I
10.1016/j.jaci.2010.07.019
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Asthma is a global health problem affecting around 300 million individuals of all ages, ethnic groups and countries. It is estimated that around 250,000 people die prematurely each year as a result of asthma. Concepts of asthma severity and control are important in evaluating patients and their response to treatment, as well as for public health, registries, and research (clinical trials, epidemiologic, genetic, and mechanistic studies), but the terminology applied is not standardized, and terms are often used interchangeably. A common international approach is favored to define severe asthma, uncontrolled asthma, and when the 2 coincide, although adaptation may be required in accordance with local conditions. A World Health Organization meeting was convened April 5-6, 2009, to propose a uniform definition of severe asthma. An article was written by a group of experts and reviewed by the Global Alliance against Chronic Respiratory Diseases review group. Severe asthma is defined by the level of current clinical control and risks as "Uncontrolled asthma which can result in risk of frequent severe exacerbations (or death) and/or adverse reactions to medications and/or chronic morbidity (including impaired lung function or reduced lung growth in children)." Severe asthma includes 3 groups, each carrying different public health messages and challenges: (1) untreated severe asthma, (2) difficult-to-treat severe asthma, and (3) treatment-resistant severe asthma. The last group includes asthma for which control is not achieved despite the highest level of recommended treatment and asthma for which control can be maintained only with the highest level of recommended treatment. (J Allergy Clin Immunol 2010; 126: 926-38.)
引用
收藏
页码:926 / 938
页数:13
相关论文
共 110 条
[91]   Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients [J].
Sullivan, S. D. ;
Wenzel, S. E. ;
Bresnahan, B. W. ;
Zheng, B. ;
Lee, J. H. ;
Pritchard, M. ;
Kamath, T. V. ;
Weiss, S. T. .
ALLERGY, 2007, 62 (06) :655-660
[92]  
Szefler S, 2000, NEW ENGL J MED, V343, P1054
[93]   MATERNAL SMOKING DURING PREGNANCY - EFFECTS ON LUNG-FUNCTION DURING THE FIRST 18 MONTHS OF LIFE [J].
TAGER, IB ;
NGO, L ;
HANRAHAN, JP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (03) :977-983
[94]   A new perspective on concepts of asthma severity and control [J].
Taylor, D. R. ;
Bateman, E. D. ;
Boulet, L-P. ;
Boushey, H. A. ;
Busse, W. W. ;
Casale, T. B. ;
Chanez, P. ;
Enright, P. L. ;
Gibson, P. G. ;
de Jongste, J. C. ;
Kerstjens, H. A. M. ;
Lazarus, S. C. ;
Levy, M. L. ;
O'Byrne, P. M. ;
Partridge, M. R. ;
Pavord, I. D. ;
Sears, M. R. ;
Sterk, P. J. ;
Stoloff, S. W. ;
Szefler, S. J. ;
Sullivan, S. D. ;
Thomas, M. D. ;
Wenzel, S. E. ;
Reddel, H. K. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (03) :545-554
[95]  
TELESDEARAUJO A, 2007, REV PORT IMUNOALERG, V15, P121
[96]   Chronic sinusitis in severe asthma is related to sputum eosinophilia [J].
ten Brinke, A ;
Grootendorst, DC ;
Schmidt, JT ;
de Bruïne, FT ;
van Buchem, MA ;
Sterk, PJ ;
Rabe, KF ;
Bel, EH .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (04) :621-626
[97]   Factors associated with persistent airflow limitation in severe asthma [J].
ten Brinke, A ;
Zwinderman, AH ;
Sterk, PJ ;
Rabe, KF ;
Bel, EH .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (05) :744-748
[98]  
Thomas Mike, 2009, Prim Care Respir J, V18, P83, DOI 10.3132/pcrj.2008.00045
[99]   Asthma in smokers: challenges and opportunities [J].
Thomson, Neil C. ;
Chaudhuri, Rekha .
CURRENT OPINION IN PULMONARY MEDICINE, 2009, 15 (01) :39-45
[100]   Asthma-related mortality in France, 1980-2005: decline since the last decade [J].
Tual, S. ;
Godard, P. ;
Piau, J. -P. ;
Bousquet, J. ;
Annesi-Maesano, I. .
ALLERGY, 2008, 63 (05) :621-623